{"entity":{"type":"insider","cik":"0001326592","url":"/insider/0001326592","json_url":"/insider/0001326592.json","name":"Hallam Trevor","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":17,"first":"2005-11-10","last":"2021-01-27","span_basis":"filed_date"},"name_variants":[{"name":"Hallam Trevor","source":"filing","n_filings":17,"first_seen":"2005-11-10","last_seen":"2021-01-27"}],"transactions":[{"id":4328833,"accession":"0001209191-21-005712","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-005712","line_url":"/filing/0001209191-21-005712","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2393.0,"shares_display":"2,393","price_per_share":25.711607814458837,"price_display":"25.71","price_state":"stated","total_value":61527.8775,"total_display":"61,527.88","total_whole":"61,528","shares_owned_after":56282.0,"shares_owned_after_display":"56,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-27","scope":"insider","n_lines":2},{"id":2085081,"accession":"0001209191-20-065371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-065371","line_url":"/filing/0001209191-20-065371#line-2","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2393.0,"shares_display":"2,393","price_per_share":22.3695,"price_display":"22.37","price_state":"stated","total_value":53530.2135,"total_display":"53,530.21","total_whole":"53,530","shares_owned_after":36712.0,"shares_owned_after_display":"36,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-28","filed_date":"2020-12-29","scope":"insider"},{"id":2560365,"accession":"0001209191-20-060756","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-060756","line_url":"/filing/0001209191-20-060756#line-2","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2393.0,"shares_display":"2,393","price_per_share":17.0134,"price_display":"17.01","price_state":"stated","total_value":40713.0662,"total_display":"40,713.07","total_whole":"40,713","shares_owned_after":36712.0,"shares_owned_after_display":"36,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-27","filed_date":"2020-11-30","scope":"insider"},{"id":2049086,"accession":"0001209191-20-057311","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-057311","line_url":"/filing/0001209191-20-057311#line-2","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16751.0,"shares_display":"16,751","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":251265.0,"total_display":"251,265.00","total_whole":"251,265","shares_owned_after":36712.0,"shares_owned_after_display":"36,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-05","filed_date":"2020-11-06","scope":"insider"},{"id":3172250,"accession":"0001209191-20-052246","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-052246","line_url":"/filing/0001209191-20-052246#line-5","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":10.2633,"price_display":"10.26","price_state":"stated","total_value":10006.7175,"total_display":"10,006.72","total_whole":"10,007","shares_owned_after":27530.0,"shares_owned_after_display":"27,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-28","filed_date":"2020-09-28","scope":"insider"},{"id":2647699,"accession":"0001209191-20-048538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-048538","line_url":"/filing/0001209191-20-048538#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":9.0444,"price_display":"9.04","price_state":"stated","total_value":8818.29,"total_display":"8,818.29","total_whole":"8,818","shares_owned_after":16790.0,"shares_owned_after_display":"16,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-26","filed_date":"2020-08-27","scope":"insider"},{"id":2141469,"accession":"0001209191-20-043857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-043857","line_url":"/filing/0001209191-20-043857#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":8.0597,"price_display":"8.06","price_state":"stated","total_value":7858.2075,"total_display":"7,858.21","total_whole":"7,858","shares_owned_after":17765.0,"shares_owned_after_display":"17,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-27","filed_date":"2020-07-28","scope":"insider"},{"id":2180620,"accession":"0001209191-20-039220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-039220","line_url":"/filing/0001209191-20-039220#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":8.0181,"price_display":"8.02","price_state":"stated","total_value":7817.6475,"total_display":"7,817.65","total_whole":"7,818","shares_owned_after":18740.0,"shares_owned_after_display":"18,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-06-29","scope":"insider"},{"id":3197913,"accession":"0001209191-20-032414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-032414","line_url":"/filing/0001209191-20-032414#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":10.0034,"price_display":"10.00","price_state":"stated","total_value":9753.315,"total_display":"9,753.32","total_whole":"9,753","shares_owned_after":19715.0,"shares_owned_after_display":"19,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-27","scope":"insider"},{"id":2831560,"accession":"0001209191-20-025882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-025882","line_url":"/filing/0001209191-20-025882","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":9.418341641025641,"price_display":"9.42","price_state":"stated","total_value":9182.8831,"total_display":"9,182.88","total_whole":"9,183","shares_owned_after":20692.0,"shares_owned_after_display":"20,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-27","filed_date":"2020-04-27","scope":"insider","n_lines":2},{"id":2897079,"accession":"0001209191-20-021438","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-021438","line_url":"/filing/0001209191-20-021438#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":9.6949,"price_display":"9.69","price_state":"stated","total_value":9452.5275,"total_display":"9,452.53","total_whole":"9,453","shares_owned_after":21665.0,"shares_owned_after_display":"21,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-26","filed_date":"2020-03-27","scope":"insider"},{"id":2268206,"accession":"0001209191-20-013478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-013478","line_url":"/filing/0001209191-20-013478#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":10.469,"price_display":"10.47","price_state":"stated","total_value":10207.275,"total_display":"10,207.28","total_whole":"10,207","shares_owned_after":22640.0,"shares_owned_after_display":"22,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-27","scope":"insider"},{"id":2974505,"accession":"0001209191-20-005159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-005159","line_url":"/filing/0001209191-20-005159#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":10.5132,"price_display":"10.51","price_state":"stated","total_value":10250.37,"total_display":"10,250.37","total_whole":"10,250","shares_owned_after":23615.0,"shares_owned_after_display":"23,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-28","scope":"insider"},{"id":7807682,"accession":"0001209191-19-062036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-062036","line_url":"/filing/0001209191-19-062036#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":11.0792,"price_display":"11.08","price_state":"stated","total_value":10802.22,"total_display":"10,802.22","total_whole":"10,802","shares_owned_after":24590.0,"shares_owned_after_display":"24,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2019-12-27","scope":"insider"},{"id":8352059,"accession":"0001209191-19-058353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-058353","line_url":"/filing/0001209191-19-058353#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":10.6772,"price_display":"10.68","price_state":"stated","total_value":10410.27,"total_display":"10,410.27","total_whole":"10,410","shares_owned_after":25565.0,"shares_owned_after_display":"25,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-27","scope":"insider"},{"id":8028665,"accession":"0001209191-19-054572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-054572","line_url":"/filing/0001209191-19-054572#line-1","is_derivative":false,"issuer_cik":"0001326592","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001326592","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":975.0,"shares_display":"975","price_per_share":9.9755,"price_display":"9.98","price_state":"stated","total_value":9726.1125,"total_display":"9,726.11","total_whole":"9,726","shares_owned_after":26540.0,"shares_owned_after_display":"26,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-28","filed_date":"2019-10-30","scope":"insider"},{"id":1538525,"accession":"0001088020-05-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001088020-05-000077","line_url":"/filing/0001088020-05-000077","is_derivative":false,"issuer_cik":"0000911216","issuer_name":"PALATIN TECHNOLOGIES INC","issuer_ticker":"PTN","issuer_name_source":null,"issuer_url":"/issuer/0000911216","owner_cik":"0001326592","owner_name":"Hallam Trevor","owner_display_name":"Hallam Trevor","owner_url":"/insider/0001326592","role":"Officer (Exec. VP - R&D)","role_mark":"O","role_mark_label":"Officer (Exec. VP - R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP - R&D","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.0236,"price_display":"2.02","price_state":"stated","total_value":5059.0,"total_display":"5,059.00","total_whole":"5,059","shares_owned_after":1700.0,"shares_owned_after_display":"1,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-10","filed_date":"2005-11-10","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001382101","name":"SUTRO BIOPHARMA, INC.","url":"/issuer/0001382101","role":"Officer (Chief Scientific Officer)","n_filings":16,"first_seen":"2019-10-30","last_seen":"2021-01-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000911216","name":"PALATIN TECHNOLOGIES INC","url":"/issuer/0000911216","role":"Officer (Exec. VP - R&D)","n_filings":1,"first_seen":"2005-11-10","last_seen":"2005-11-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001326592","retrieved_at":"2026-08-25T17:44:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}